BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33583641)

  • 1. Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Grimm J; Vargo JA; Mavroidis P; Moiseenko V; Emami B; Jain S; Caudell JJ; Clump DA; Ling DC; Das S; Moros EG; Vinogradskiy Y; Xue J; Heron DE
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):147-159. PubMed ID: 33583641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of carotid blowout after reirradiation of the head and neck: a systematic review.
    McDonald MW; Moore MG; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1083-9. PubMed ID: 21549520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
    Sahgal A; Chang JH; Ma L; Marks LB; Milano MT; Medin P; Niemierko A; Soltys SG; Tomé WA; Wong CS; Yorke E; Grimm J; Jackson A
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):124-136. PubMed ID: 31606528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis.
    Yamazaki H; Ogita M; Himei K; Nakamura S; Kotsuma T; Yoshida K; Yoshioka Y
    Radiother Oncol; 2015 Apr; 115(1):67-71. PubMed ID: 25827266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Mahadevan A; Moningi S; Grimm J; Li XA; Forster KM; Palta M; Prior P; Goodman KA; Narang A; Heron DE; Lo SS; Urbanic J; Herman JM
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):206-216. PubMed ID: 33358561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitting NTCP models to SBRT dose and carotid blowout syndrome data.
    Mavroidis P; Grimm J; Cengiz M; Das S; Tan X; Yazici G; Ozyigit G
    Med Phys; 2018 Oct; 45(10):4754-4762. PubMed ID: 30102783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.
    Sahgal A; Ma L; Weinberg V; Gibbs IC; Chao S; Chang UK; Werner-Wasik M; Angelov L; Chang EL; Sohn MJ; Soltys SG; Létourneau D; Ryu S; Gerszten PC; Fowler J; Wong CS; Larson DA
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):107-16. PubMed ID: 20951503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation dose-volume effects in the spinal cord.
    Kirkpatrick JP; van der Kogel AJ; Schultheiss TE
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3 Suppl):S42-9. PubMed ID: 20171517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation myelopathy following stereotactic body radiation therapy for spine metastases.
    Ong WL; Wong S; Soliman H; Myrehaug S; Tseng CL; Detsky J; Husain Z; Maralani P; Ma L; Lo SS; Sahgal A
    J Neurooncol; 2022 Aug; 159(1):23-31. PubMed ID: 35737172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer.
    Ling DC; Vargo JA; Gebhardt BJ; Grimm RJ; Clump DA; Ferris RL; Ohr JP; Heron DE
    J Radiosurg SBRT; 2019; 6(2):83-89. PubMed ID: 31641545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: a modelling-based approach from clinical experience.
    Kapitanova I; Biswas S; Divekar S; Kemmerer EJ; Rostock RA; Forster KM; Grimm RJ; Scofield CJ; Grimm J; Emami B; Mahadevan A
    Radiat Oncol; 2021 Jun; 16(1):98. PubMed ID: 34098991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid blowout syndrome in patients with head-and-neck cancers: reconstructive management by self-expandable stent-grafts.
    Chang FC; Lirng JF; Luo CB; Guo WY; Teng MM; Tai SK; Chang CY
    AJNR Am J Neuroradiol; 2007 Jan; 28(1):181-8. PubMed ID: 17213454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
    Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M
    Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group.
    Vargo JA; Moiseenko V; Grimm J; Caudell J; Clump DA; Yorke E; Xue J; Vinogradskiy Y; Moros EG; Mavroidis P; Jain S; El Naqa I; Marks LB; Heron DE
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):137-146. PubMed ID: 29477291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.